[DPHARMA] QoQ TTM Result on 31-Dec-2021 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
15-Feb-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
31-Dec-2021 [#4]
Profit Trend
QoQ- -0.72%
YoY- 12.07%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 690,201 684,965 658,662 639,175 627,817 589,751 577,643 12.58%
PBT 86,632 87,730 86,454 82,984 86,327 82,412 81,606 4.06%
Tax -17,965 -18,449 -18,094 -17,301 -20,167 -19,088 -18,943 -3.46%
NP 68,667 69,281 68,360 65,683 66,160 63,324 62,663 6.28%
-
NP to SH 68,667 69,281 68,360 65,683 66,160 63,324 62,663 6.28%
-
Tax Rate 20.74% 21.03% 20.93% 20.85% 23.36% 23.16% 23.21% -
Total Cost 621,534 615,684 590,302 573,492 561,657 526,427 514,980 13.34%
-
Net Worth 647,522 634,375 621,987 621,564 612,147 614,350 635,424 1.26%
Dividend
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Div 21,685 21,685 20,482 20,482 45,892 45,892 45,783 -39.20%
Div Payout % 31.58% 31.30% 29.96% 31.18% 69.37% 72.47% 73.06% -
Equity
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Net Worth 647,522 634,375 621,987 621,564 612,147 614,350 635,424 1.26%
NOSH 952,239 952,239 941,765 941,765 941,765 706,330 706,026 22.05%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 9.95% 10.11% 10.38% 10.28% 10.54% 10.74% 10.85% -
ROE 10.60% 10.92% 10.99% 10.57% 10.81% 10.31% 9.86% -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 72.48 72.34 70.95 67.87 66.66 83.52 81.82 -7.75%
EPS 7.21 7.32 7.36 6.97 7.03 8.97 8.88 -12.95%
DPS 2.28 2.30 2.21 2.17 4.87 6.50 6.48 -50.12%
NAPS 0.68 0.67 0.67 0.66 0.65 0.87 0.90 -17.03%
Adjusted Per Share Value based on latest NOSH - 941,765
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 71.75 71.21 68.47 66.45 65.27 61.31 60.05 12.58%
EPS 7.14 7.20 7.11 6.83 6.88 6.58 6.51 6.34%
DPS 2.25 2.25 2.13 2.13 4.77 4.77 4.76 -39.29%
NAPS 0.6731 0.6595 0.6466 0.6462 0.6364 0.6387 0.6606 1.25%
Price Multiplier on Financial Quarter End Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 -
Price 1.30 1.20 1.49 1.68 1.81 3.03 2.75 -
P/RPS 1.79 1.66 2.10 2.48 2.72 3.63 3.36 -34.25%
P/EPS 18.03 16.40 20.23 24.09 25.76 33.79 30.98 -30.27%
EY 5.55 6.10 4.94 4.15 3.88 2.96 3.23 43.41%
DY 1.75 1.92 1.48 1.29 2.69 2.15 2.36 -18.05%
P/NAPS 1.91 1.79 2.22 2.55 2.78 3.48 3.06 -26.94%
Price Multiplier on Announcement Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 09/11/22 16/08/22 17/05/22 15/02/22 18/11/21 17/08/21 03/05/21 -
Price 1.39 1.34 1.51 1.60 1.62 2.49 2.93 -
P/RPS 1.92 1.85 2.13 2.36 2.43 2.98 3.58 -33.96%
P/EPS 19.28 18.31 20.51 22.94 23.06 27.77 33.01 -30.10%
EY 5.19 5.46 4.88 4.36 4.34 3.60 3.03 43.11%
DY 1.64 1.72 1.46 1.36 3.01 2.61 2.21 -18.01%
P/NAPS 2.04 2.00 2.25 2.42 2.49 2.86 3.26 -26.81%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment